'The healthcare imaging software provider’s shares have come under pressure since the release of a broker note out of UBS on Tuesday. It downgraded its shares to a neutral rating with a $29.65 price target. While the broker likes Pro Medicus and was pleased with its latest contract win, it isn’t a fan of its current valuation.'
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$317.34 |
Change
-0.350(0.11%) |
Mkt cap ! $33.15B | |||
| Open | High | Low | Value | Volume |
| $318.00 | $320.18 | $313.61 | $58.36M | 184.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 490 | $317.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $317.34 | 226 | 2 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| PME (ASX) Chart |